Home Biosimilar Antibodies Microbiology SARS-CoV antibody Gimsilumab (Anti-CSF2 / GM-CSF) For research use only.
Not for use in humans.

Gimsilumab (Anti-CSF2 / GM-CSF)

Synonyms: MORAb-022

Gimsilumab (Anti-CSF2 / GM-CSF) is a human immunoglobulin G1 (IgG1) monoclonal antibody directed against the myeloid cell growth factor and inflammatory mediator granulocyte-macrophage colony-stimulating factor (GM-CSF) with potential immunomodulating activity. MW : 145.8 KD.

Gimsilumab (Anti-CSF2 / GM-CSF)

Purity & Quality Control

≥99

Choose Selective SARS-CoV Inhibitors

Biological Activity

Description Gimsilumab (Anti-CSF2 / GM-CSF) is a human immunoglobulin G1 (IgG1) monoclonal antibody directed against the myeloid cell growth factor and inflammatory mediator granulocyte-macrophage colony-stimulating factor (GM-CSF) with potential immunomodulating activity. MW : 145.8 KD.

Product Details

CAS No. 1648796-29-5
Molecular Weight 145.8
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Gimsilumab (Anti-CSF2 / GM-CSF) | Gimsilumab (Anti-CSF2 / GM-CSF) supplier | purchase Gimsilumab (Anti-CSF2 / GM-CSF) | Gimsilumab (Anti-CSF2 / GM-CSF) cost | Gimsilumab (Anti-CSF2 / GM-CSF) manufacturer | order Gimsilumab (Anti-CSF2 / GM-CSF) | Gimsilumab (Anti-CSF2 / GM-CSF) distributor